Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
1
Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Universita’ di Padova, Padova 35128, Italy
2
UOC Immunologia e Diagnostica Molecolare Oncologica, Istituto Oncologico Veneto IOV—IRCCS, Padova 35128, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(9), 1904; https://doi.org/10.3390/ijms18091904
Received: 8 August 2017 / Revised: 30 August 2017 / Accepted: 1 September 2017 / Published: 5 September 2017
(This article belongs to the Special Issue Alterations to Signalling Pathways in Cancer Cells)
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the malignant transformation of immature progenitors primed towards T-cell development. Clinically, T-ALL patients present with diffuse infiltration of the bone marrow by immature T-cell blasts high blood cell counts, mediastinal involvement, and diffusion to the central nervous system. In the past decade, the genomic landscape of T-ALL has been the target of intense research. The identification of specific genomic alterations has contributed to identify strong oncogenic drivers and signaling pathways regulating leukemia growth. Notwithstanding, T-ALL patients are still treated with high-dose multiagent chemotherapy, potentially exposing these patients to considerable acute and long-term side effects. This review summarizes recent advances in our understanding of the signaling pathways relevant for the pathogenesis of T-ALL and the opportunities offered for targeted therapy.
View Full-Text
Keywords:
acute lymphoblastic leukemia; oncogenes; PI3K/AKT; targeted therapy
▼
Show Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Bongiovanni, D.; Saccomani, V.; Piovan, E. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci. 2017, 18, 1904. https://doi.org/10.3390/ijms18091904
AMA Style
Bongiovanni D, Saccomani V, Piovan E. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2017; 18(9):1904. https://doi.org/10.3390/ijms18091904
Chicago/Turabian StyleBongiovanni, Deborah; Saccomani, Valentina; Piovan, Erich. 2017. "Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia" Int. J. Mol. Sci. 18, no. 9: 1904. https://doi.org/10.3390/ijms18091904
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit